215 related articles for article (PubMed ID: 12079830)
1. PPARs: transcription factors controlling lipid and lipoprotein metabolism.
Bocher V; Pineda-Torra I; Fruchart JC; Staels B
Ann N Y Acad Sci; 2002 Jun; 967():7-18. PubMed ID: 12079830
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation.
Chinetti G; Fruchart JC; Staels B
Inflamm Res; 2000 Oct; 49(10):497-505. PubMed ID: 11089900
[TBL] [Abstract][Full Text] [Related]
3. Regulation of lipid and lipoprotein metabolism by PPAR activators.
Gervois P; Torra IP; Fruchart JC; Staels B
Clin Chem Lab Med; 2000 Jan; 38(1):3-11. PubMed ID: 10774955
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells.
Marx N; Duez H; Fruchart JC; Staels B
Circ Res; 2004 May; 94(9):1168-78. PubMed ID: 15142970
[TBL] [Abstract][Full Text] [Related]
5. The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation.
Schoonjans K; Staels B; Auwerx J
Biochim Biophys Acta; 1996 Jul; 1302(2):93-109. PubMed ID: 8695669
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism.
Gilde AJ; van der Lee KA; Willemsen PH; Chinetti G; van der Leij FR; van der Vusse GJ; Staels B; van Bilsen M
Circ Res; 2003 Mar; 92(5):518-24. PubMed ID: 12600885
[TBL] [Abstract][Full Text] [Related]
7. The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells.
Dressel U; Allen TL; Pippal JB; Rohde PR; Lau P; Muscat GE
Mol Endocrinol; 2003 Dec; 17(12):2477-93. PubMed ID: 14525954
[TBL] [Abstract][Full Text] [Related]
8. Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis.
Barbier O; Torra IP; Duguay Y; Blanquart C; Fruchart JC; Glineur C; Staels B
Arterioscler Thromb Vasc Biol; 2002 May; 22(5):717-26. PubMed ID: 12006382
[TBL] [Abstract][Full Text] [Related]
9. [Role of the peroxisome proliferator-activated receptors (PPARS) in the regulation of lipids and inflammation control].
Bocher V; Chinetti G; Fruchart JC; Staels B
J Soc Biol; 2002; 196(1):47-52. PubMed ID: 12134632
[TBL] [Abstract][Full Text] [Related]
10. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression.
Schoonjans K; Staels B; Auwerx J
J Lipid Res; 1996 May; 37(5):907-25. PubMed ID: 8725145
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptors, orphans with ligands and functions.
Schoonjans K; Martin G; Staels B; Auwerx J
Curr Opin Lipidol; 1997 Jun; 8(3):159-66. PubMed ID: 9211064
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptors: from genes to physiology.
Kliewer SA; Xu HE; Lambert MH; Willson TM
Recent Prog Horm Res; 2001; 56():239-63. PubMed ID: 11237216
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism.
Latruffe N; Vamecq J
Biochimie; 1997; 79(2-3):81-94. PubMed ID: 9209701
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors with functions in the vascular wall.
Chinetti G; Fruchart JC; Staels B
Z Kardiol; 2001; 90 Suppl 3():125-32. PubMed ID: 11374025
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease.
Guan Y; Breyer MD
Kidney Int; 2001 Jul; 60(1):14-30. PubMed ID: 11422732
[TBL] [Abstract][Full Text] [Related]
16. PPARS in inflammation, atherosclerosis and thrombosis.
Duez H; Fruchart JC; Staels B
J Cardiovasc Risk; 2001 Aug; 8(4):187-94. PubMed ID: 11550996
[TBL] [Abstract][Full Text] [Related]
17. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay.
Krey G; Braissant O; L'Horset F; Kalkhoven E; Perroud M; Parker MG; Wahli W
Mol Endocrinol; 1997 Jun; 11(6):779-91. PubMed ID: 9171241
[TBL] [Abstract][Full Text] [Related]
18. Physiological and therapeutic roles of peroxisome proliferator-activated receptors.
Berger J; Wagner JA
Diabetes Technol Ther; 2002; 4(2):163-74. PubMed ID: 12079620
[TBL] [Abstract][Full Text] [Related]
19. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma.
Kliewer SA; Sundseth SS; Jones SA; Brown PJ; Wisely GB; Koble CS; Devchand P; Wahli W; Willson TM; Lenhard JM; Lehmann JM
Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4318-23. PubMed ID: 9113987
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis.
Fruchart JC; Duriez P; Staels B
Curr Opin Lipidol; 1999 Jun; 10(3):245-57. PubMed ID: 10431661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
